Prestige Consumer Healthcare (PBH) Acquisitions (2014 - 2022)

Prestige Consumer Healthcare (PBH) recorded quarterly Acquisitions of $132000.0 in Q1 2022, down 99.27% quarter-over-quarter from $18.0 million in Q4 2021.

Prestige Consumer Healthcare (PBH) Acquisitions (2014 - 2022) Analysis & Trends

Prestige Consumer Healthcare's Acquisitions history runs 5 years deep, the most recent figure standing at $132000.0 for Q1 2022.

  • In Q1 2022, Acquisitions changed N/A year-over-year to $132000.0; the TTM figure through Mar 2023 stood at $18.1 million (changed 0.0% YoY), while the FY2022 annual figure was $247.0 million, changed N/A from the prior year.
  • Acquisitions was $132000.0 for Q1 2022 at Prestige Consumer Healthcare, down from $18.0 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $18.0 million in Q4 2021 to a low of $132000.0 in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.09 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 137.87 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Prestige Consumer Healthcare 2.37 Bn 2.31 Bn 157.37 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2022 132,000.00
Dec 31, 2021 18.00 Mn
Jun 30, 2017 970,000.00
Dec 31, 2016 1.40 Mn
Dec 31, 2014 -77.99 Mn
Jun 30, 2014 77.99 Mn